All In Biotech

Drug Trial Radar · NCT06716645

A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin

A Real-World Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin

Last checked: Nov 19, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 244 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

244

Actual

Start

Dec 4, 2024

Primary completion

Feb 14, 2025

Study completion Feb 14, 2025

Sponsor

Lead sponsor
HALEONIndustry
Sponsor type
Industry
First posted
Dec 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Real-World Evidence study is to generate real world data from participants with cough associated with the common cold, evaluating the effects in two arms with commercially available cough syrups on health-related quality of life (QoL). Arm 1 includes one cough syrup (which can be used day or night) and Arm 2 includes the daytime cough syrup and a nighttime cough syrup.

Conditions

  • Common Cold
  • Cough

Interventions

  • Robitussin Maximum Strength Cough and Chest Congestion DMDrug

    Dextromethorphan Hydrobromide, United States Pharmacopeia (USP) 20 milligram (mg) and Guaifenesin, USP 400 mg

  • Robitussin Maximum Strength Cough and Chest Congestion DMDrug

    Dextromethorphan Hydrobromide, USP 20 mg and Guaifenesin, USP 400 mg

  • Robitussin Maximum Strength Nighttime Cough DMDrug

    Dextromethorphan Hydrobromide, USP 30 mg and Doxylamine Succinate, USP 12.5 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adjusted Mean Change From Baseline in Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21) Total ScoreTime frame: Baseline and up to Day 7 or End of Treatment (EOT)
  2. Adjusted Mean Change From Baseline in WURSS-21 Total Symptom Domain ScoreTime frame: Baseline and up to Day 7 or EOT
  3. Adjusted Mean Change From Baseline in WURSS-21 Total QoL Domain ScoreTime frame: Baseline and up to Day 7 or EOT
  4. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: CoughTime frame: Baseline and up to Day 7 or EOT
  5. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Runny NoseTime frame: Baseline and up to Day 7 or EOT
  6. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Plugged NoseTime frame: Baseline and up to Day 7 or EOT
  7. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: SneezingTime frame: Baseline and up to Day 7 or EOT
  8. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Sore ThroatTime frame: Baseline and up to Day 7 or EOT
  9. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Scratchy ThroatTime frame: Baseline and up to Day 7 or EOT
  10. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: HoarsenessTime frame: Baseline and up to Day 7 or EOT
  11. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Head CongestionTime frame: Baseline and up to Day 7 or EOT
  12. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Chest CongestionTime frame: Baseline and up to Day 7 or EOT
  13. Mean Change From Baseline in Each of the WURSS-21 Symptom Scores: Feeling TiredTime frame: Baseline and up to Day 7 or EOT
  14. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Think ClearlyTime frame: Baseline and up to Day 7 or EOT
  15. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Sleep WellTime frame: Baseline and up to Day 7 or EOT
  16. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Breathe EasilyTime frame: Baseline and up to Day 7 or EOT
  17. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Walk, Climb Stairs, ExerciseTime frame: Baseline and up to Day 7 or EOT
  18. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Accomplish Daily ActivitiesTime frame: Baseline and up to Day 7 or EOT
  19. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Work Outside the HomeTime frame: Baseline and up to Day 7 or EOT
  20. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Work Inside the HomeTime frame: Baseline and up to Day 7 or EOT
  21. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Interact With OthersTime frame: Baseline and up to Day 7 or EOT
  22. Mean Change From Baseline in Each of the WURSS-21 QoL Questions Scores: Live Your Personal LifeTime frame: Baseline and up to Day 7 or EOT

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lindus Health Limited

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.